• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy

tetano

Editor, Senior Moderator
Am J Hum Genet. 2015 Jan 8;96(1):136-46. doi: 10.1016/j.ajhg.2014.12.010.
[h=1]HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy.[/h] Ollila HM[SUP]1[/SUP], Ravel JM[SUP]1[/SUP], Han F[SUP]2[/SUP], Faraco J[SUP]1[/SUP], Lin L[SUP]1[/SUP], Zheng X[SUP]3[/SUP], Plazzi G[SUP]4[/SUP], Dauvilliers Y[SUP]5[/SUP], Pizza F[SUP]4[/SUP], Hong SC[SUP]6[/SUP], Jennum P[SUP]7[/SUP], Knudsen S[SUP]8[/SUP], Kornum BR[SUP]9[/SUP], Dong XS[SUP]2[/SUP], Yan H[SUP]2[/SUP], Hong H[SUP]1[/SUP], Coquillard C[SUP]10[/SUP], Mahlios J[SUP]1[/SUP], Jolanki O[SUP]1[/SUP], Einen M[SUP]1[/SUP], Lavault S[SUP]11[/SUP], H?gl B[SUP]12[/SUP], Frauscher B[SUP]12[/SUP], Crowe C[SUP]13[/SUP], Partinen M[SUP]14[/SUP], Huang YS[SUP]15[/SUP], Bourgin P[SUP]16[/SUP], Vaarala O[SUP]17[/SUP], D?sautels A[SUP]18[/SUP], Montplaisir J[SUP]19[/SUP], Mack SJ[SUP]20[/SUP], Mindrinos M[SUP]21[/SUP], Fernandez-Vina M[SUP]10[/SUP], Mignot E[SUP]22[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Type 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly associated with human leukocyte antigen (HLA) class II HLA-DQA1(∗)01:02-DQB1(∗)06:02 (DQ0602) that very few non-DQ0602 cases have been reported. A known triggering factor for narcolepsy is pandemic 2009 influenza H1N1, suggesting autoimmunity triggered by upper-airway infections. Additional effects of other HLA-DQ alleles have been reported consistently across multiple ethnic groups. Using over 3,000 case and 10,000 control individuals of European and Chinese background, we examined the effects of other HLA loci. After careful matching of HLA-DR and HLA-DQ in case and control individuals, we found strong protective effects of HLA-DPA1(∗)01:03-DPB1(∗)04:02 (DP0402; odds ratio [OR] = 0.51 [0.38-0.67], p = 1.01 ? 10(-6)) and HLA-DPA1(∗)01:03-DPB1(∗)04:01 (DP0401; OR = 0.61 [0.47-0.80], p = 2.07 ? 10(-4)) and predisposing effects of HLA-DPB1(∗)05:01 in Asians (OR = 1.76 [1.34-2.31], p = 4.71 ? 10(-05)). Similar effects were found by conditional analysis controlling for HLA-DR and HLA-DQ with DP0402 (OR = 0.45 [0.38-0.55] p = 8.99 ? 10(-17)) and DP0501 (OR = 1.38 [1.18-1.61], p = 7.11 ? 10(-5)). HLA-class-II-independent associations with HLA-A(∗)11:01 (OR = 1.32 [1.13-1.54], p = 4.92 ? 10(-4)), HLA-B(∗)35:03 (OR = 1.96 [1.41-2.70], p = 5.14 ? 10(-5)), and HLA-B(∗)51:01 (OR = 1.49 [1.25-1.78], p = 1.09 ? 10(-5)) were also seen across ethnic groups in the HLA class I region. These effects might reflect modulation of autoimmunity or indirect effects of HLA class I and HLA-DP alleles on response to viral infections such as that of influenza.
Copyright ? 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.


PMID: 25574827 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25574827
 
Back
Top Bottom